Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (10160)	10/26/1997 12:15:00 AM
From: Hippieslayer	Read Replies (1) \| Respond to of 32384

To Anyone who is interested: I was listening to Bob Brinker today and he mentioned an article that appears in this weeks Barrons. Looks like The US Gov--not sure which branch--is investagating many big pharma's for bilking taxpayers of millions of dollars over the pricing of drugs (something along that line). Brinker mentioned names but did not mention LLY. Could put a temporary cloud over the sector if it gets a lot of coverage.

To: Henry Niman who wrote (10160)	10/26/1997 12:12:00 PM
From: targetedmoab	Read Replies (1) \| Respond to of 32384

Henry, Just kind of curious on your prediction for the next few months with Lgnd. As far as I can see it, unless some major breaktrough news comes through, it will bounce between 14-17 until 98. I've read a number of posts wondering why Immunex went up while Ligand isnt. Immunex has about 160 million in sales/year and a major RA drug (billion potential), released probably within a year. They also has a number of molecules starting or in phase II. I know there are a number of options players here and im sure they would like to know your take too. Thanks Steve